A PHASE-I CLINICAL-TRIAL FOR PATIENTS WITH METASTATIC MELANOMA USING AUTOLOGOUS IL2 SECRETING MELANOMA AS A VACCINE

Citation
K. Palmer et al., A PHASE-I CLINICAL-TRIAL FOR PATIENTS WITH METASTATIC MELANOMA USING AUTOLOGOUS IL2 SECRETING MELANOMA AS A VACCINE, Cancer gene therapy, 4(5), 1997, pp. 336-336
Citations number
1
Categorie Soggetti
Oncology,"Biothechnology & Applied Migrobiology
Journal title
ISSN journal
09291903
Volume
4
Issue
5
Year of publication
1997
Pages
336 - 336
Database
ISI
SICI code
0929-1903(1997)4:5<336:APCFPW>2.0.ZU;2-3